Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.12% | 20.81% | 17.97% | 18.89% | 36.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.12% | 20.81% | 17.97% | 18.89% | 36.55% |
| Cost of Revenue | -2.06% | -4.33% | 13.56% | 29.46% | 44.30% |
| Gross Profit | 19.24% | 32.23% | 19.63% | 15.39% | 33.66% |
| SG&A Expenses | 22.29% | 19.64% | 20.26% | 24.94% | 29.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.80% | 11.18% | 16.97% | 24.69% | 25.86% |
| Operating Income | -20.11% | 11.69% | -13.79% | -48.18% | -0.86% |
| Income Before Tax | -23.13% | 14.12% | -3.04% | -23.93% | 12.43% |
| Income Tax Expenses | -- | -- | 48.28% | -- | -- |
| Earnings from Continuing Operations | -23.13% | 14.12% | -3.15% | -23.93% | 12.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.13% | 14.12% | -3.15% | -23.93% | 12.43% |
| EBIT | -20.11% | 11.69% | -13.79% | -48.18% | -0.86% |
| EBITDA | -21.27% | 11.85% | -14.61% | -49.89% | 0.45% |
| EPS Basic | -20.47% | 15.73% | 0.66% | -12.56% | 20.63% |
| Normalized Basic EPS | -20.47% | 15.73% | 0.86% | -12.53% | 19.33% |
| EPS Diluted | -20.47% | 15.73% | 0.66% | -12.56% | 20.63% |
| Normalized Diluted EPS | -20.47% | 15.73% | 0.86% | -12.53% | 19.33% |
| Average Basic Shares Outstanding | 2.21% | 1.89% | 3.83% | 10.09% | 10.31% |
| Average Diluted Shares Outstanding | 2.21% | 1.89% | 3.83% | 10.09% | 10.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
